- Home
- CAAP vs PRCT Comparison
CAAP vs PRCT Comparison
Compare CAAP & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- PRCT
- Stock Information
- Founded
- CAAP 1998
- PRCT 2009
- Country
- CAAP Luxembourg
- PRCT United States
- Employees
- CAAP N/A
- PRCT 756
- Industry
- CAAP Aerospace
- PRCT Medical Specialities
- Sector
- CAAP Consumer Discretionary
- PRCT Health Care
- Exchange
- CAAP Nasdaq
- PRCT Nasdaq
- Market Cap
- CAAP 3.3B
- PRCT 3.2B
- IPO Year
- CAAP 2018
- PRCT 2021
- Fundamental
- Price
- CAAP $19.27
- PRCT $56.65
- Analyst Decision
- CAAP Strong Buy
- PRCT Buy
- Analyst Count
- CAAP 2
- PRCT 8
- Target Price
- CAAP $24.35
- PRCT $90.00
- AVG Volume (30 Days)
- CAAP 120.7K
- PRCT 654.3K
- Earning Date
- CAAP 08-20-2025
- PRCT 07-31-2025
- Dividend Yield
- CAAP N/A
- PRCT N/A
- EPS Growth
- CAAP N/A
- PRCT N/A
- EPS
- CAAP 1.05
- PRCT N/A
- Revenue
- CAAP $1,858,038,000.00
- PRCT $249,121,000.00
- Revenue This Year
- CAAP N/A
- PRCT $47.40
- Revenue Next Year
- CAAP $12.97
- PRCT $31.55
- P/E Ratio
- CAAP $18.35
- PRCT N/A
- Revenue Growth
- CAAP 28.46
- PRCT 59.36
- 52 Week Low
- CAAP $13.97
- PRCT $47.04
- 52 Week High
- CAAP $22.13
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- CAAP 38.12
- PRCT 43.88
- Support Level
- CAAP $19.82
- PRCT $56.67
- Resistance Level
- CAAP $20.70
- PRCT $60.06
- Average True Range (ATR)
- CAAP 0.56
- PRCT 1.96
- MACD
- CAAP -0.05
- PRCT -0.17
- Stochastic Oscillator
- CAAP 3.06
- PRCT 15.08
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.